{
    "Project Title": "NIS-PSO-TARGET Non-Interventional Study Protocol",
    "Sponsor": "LEO Pharma France",
    "Study Number": "RCB: 2020-A00652-37",
    "Protocol Version and Date": "Not Available",
    "Study Title": "NIS-PSO-TARGET Non-Interventional Study Protocol",
    "Phase": "Not Available",
    "Therapeutic Area": "Psoriasis",
    "Number of Patients": "150",
    "Number of Sites": "Approximately 25 sites",
    "Indication": "Psoriasis vulgaris",
    "Duration of Treatment": "52 weeks",
    "Schedule of Assessments": "Not Available",
    "questionnaires": [
        {
            "longName": "Psoriasis Area and Severity Index",
            "shortName": "PASI",
            "type": "ClinRO",
            "questionnaireSchedule": "Collected at baseline, 12 weeks, and 52 weeks.",
            "questionnaireTiming": [
                "Base-line Visit (Day 0)",
                "3 months Visit (week 12-16)",
                "12 months visit (week 48-56)"
            ]
        },
        {
            "longName": "Dermatology Life Quality Index",
            "shortName": "DLQI",
            "type": "PRO",
            "questionnaireSchedule": "Collected at baseline, 12 weeks, and 52 weeks.",
            "questionnaireTiming": [
                "Base-line Visit (Day 0)",
                "3 months Visit (week 12-16)",
                "12 months visit (week 48-56)"
            ]
        },
        {
            "longName": "PSO-TARGET Quality of Life Component Grid",
            "shortName": "PSO-TARGET",
            "type": "PRO",
            "questionnaireSchedule": "Collected at baseline and 12 weeks.",
            "questionnaireTiming": [
                "Base-line Visit (Day 0)",
                "3 months Visit (week 12-16)",
                "12 months visit (week 48-56)"
            ]
        }
    ]
}